Clinical Trials
11 trialsNCT07377487 2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA Recruiting
NCT06794073 2026-05-11
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
Shanghai Zhongshan Hospital
Phase NA Recruiting
NCT04929015 2026-05-04
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)
Rutgers, The State University of New Jersey
Phase NA Suspended
NCT04084249 2026-04-29
ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial
University of Aarhus
Phase NA Active not recruiting
NCT03221335 2026-03-20
EUS-guided RFA for Solid Abdominal Neoplasms
Chinese University of Hong Kong
Phase NA Recruiting
NCT06263205 2026-03-03
Dressing
Fudan University
Phase NA Completed
NCT07404527 2026-02-13
Bioelectrical Impedance Analysis for Perioperative Fluid Evaluation in Colorectal Cancer Surgery
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT06715839 2025-12-31
Target-specific immunoPET Imaging of Digestive System Carcinoma
RenJi Hospital
Phase NA Recruiting
NCT03508180 2025-12-19
REFYO-R
Hospices Civils de Lyon
Phase NA Completed
NCT04556344 2025-12-05
EmoVie_K2
University Hospital, Lille
Phase NA Completed
NCT07104877 2025-08-05
A Study of SYS6010 in Combination With SYH2051 in Patients With Advanced Colorectal Cancer and Other Gastrointestinal Tumors
Fujian Cancer Hospital
Phase NA Active not recruiting